Delivery Order V797D60737-36C26226F0170
- The Department of Veterans Affairs, through Veterans Integrated Service Network 17, awarded a delivery order valued at $145,785.00 to INO Therapeutics LLC for nitric oxide inhalation therapy services. This firm fixed-price contract, issued without a set-aside designation, is scheduled for completion by February 4, 2030, and will be performed in San Antonio, Texas. The delivery order is issued under the parent Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), leveraging existing...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic gases and respiratory therapy systems, was awarded a delivery order valued at $51,982.38 by Veterans Integrated Service Network 22, a civilian component of the Department of Veterans Affairs. The contract, issued March 1, 2024, with an ultimate completion date of February 28, 2025, operates under a firm fixed-price structure and is classified as a non-set-aside award. Performance will be executed at the...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide (INO) therapeutic solutions, received a delivery order valued at $53,381.63 from Veterans Integrated Service Network 19 (VISN 19) for the provision of inotherapy nitric oxide gas therapy and related services. Issued as a firm fixed-price contract on May 27, 2021, with an ultimate completion date of May 26, 2026, this non-set-aside delivery order will be performed in Hazelwood, Missouri. The contract represents a continuation...
- INO Therapeutics LLC, a foreign-owned supplier of specialized respiratory therapeutic gases headquartered in Hazelwood, Missouri, received a $853,273.62 firm fixed-price delivery order from Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs. The delivery order, issued on October 1, 2022, with ultimate completion targeted for September 30, 2027, represents a call against the company's existing Blanket Purchase Agreement with VISN 2 under the...
- INO Therapeutics LLC was awarded a delivery order valued at $341,058.70 by Veterans Integrated Service Network (VISN) 5 for the supply of inhaled nitric oxide (INO) therapeutic gas to the Nitric Oxide Division at the Durham VA Medical Center (VAMC). This firm fixed-price contract, awarded on March 16, 2020, with a completion date of March 15, 2025, represents a continuation of the company's primary service offering—specialized medical gas delivery to federal healthcare facilities. The award...
- On October 21, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order to INO Therapeutics LLC valued at $80,840 for the supply of INOMAX (nitric oxide) gas. This is a firm fixed price, non-set-aside contract issued under the parent GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), with an ultimate completion date of October 20, 2026. The place of performance is Durham, North Carolina. INO Therapeutics LLC, headquartered...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic solutions, was awarded a contract valued at $66,029.21 by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for inhalation therapy services supporting Veterans Administration medical facilities in California. The contract, awarded June 1, 2021, was issued as a call against an existing Blanket Purchase Agreement (BPA) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB)...
- INO Therapeutics LLC, a Hazelwood, Missouri-based supplier of inhaled nitric oxide (INO) therapeutic gases and related medical services, was awarded a $321,643 firm fixed-price delivery order by Veterans Integrated Service Network 10 on April 27, 2022. This non-set-aside contract, with an ultimate completion date of April 26, 2027, falls under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and represents a task order issued against a larger Indefinite Delivery/Indefinite...
- This is a federal contract award made by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to INO Therapeutics LLC, a for-profit company that provides inhaled nitric oxide therapy systems and related medical gases. The contract, valued at $323,299.11, is a delivery order under the VA's Pharmaceuticals and Drugs GSA Schedule. It is for the supply of nitric oxide gas to support respiratory treatments and related healthcare programs for veterans...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to INO Therapeutics LLC, a prime contractor providing inhaled nitric oxide therapy to improve oxygenation for veteran patients. The $16,135.00 contract was awarded on October 1, 2022 under the VA's Pharmaceuticals and Drugs GSA Schedule 61-IB, with a performance period ending on March 30, 2024. The contract does not have a set-aside designation. As a long-standing provider of these niche medical...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D60737Federal Supply Schedule
- V797D60737-36C26226F0170Delivery Order
The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a $10,794.00 delivery order to INO Therapeutics LLC on March 1, 2026, for the provision of nitric oxide gas services with an ultimate completion date of August 31, 2026. This is a firm fixed-price contract with no set-aside designation, issued as a child order under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). The work will be performed in San Diego, California, supporting the VA's healthcare delivery mission. INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic gases and respiratory therapy systems, is well-established as a critical vendor to federal healthcare agencies. The contractor holds multiple active Blanket Purchase Agreements with the VA and Defense Health Agency, including a VISN 2 BPA valued at $789,408.92 for INOMAX nitric oxide gas cylinder delivery services through September 2027. INO Therapeutics provides INOMAX cylinders, delivery equipment, and comprehensive inhalation therapy services to support neonatal, pediatric, and adult critical care patient populations across the federal healthcare system, with a proven track record of performance across numerous VA medical centers and military medical facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 2/25/26 |